checkAd
    Startseite > Aktien > Biocept > Nachrichten
    Biocept Aktie
    0,2103
     
    USD
    0,00 %
    0,0000 USD
    Letzter Kurs 17.05.23 Nasdaq
    0,2102
     
    USD
    4.800 STK
    Geldkurs 16.05.23
    0,2197
     
    USD
    100 STK
    Briefkurs 16.05.23
    ISIN: US09072V5012 · WKN: A2QEQE · SYM: BIOC · USA

    Neueste Nachrichten

    Enrollment Completed in the Feasibility Phase of the FORESEE Clinical Trial with Biocept’s CNSide Assay to Evaluate Patients with Leptomeningeal Metastases
    21.09.23 · Business Wire (engl.) · Biocept
    Biocept Signs CNSide Licensing Agreement with Plus Therapeutics
    08.09.23 · Business Wire (engl.) · Biocept
    Biocept to Participate in the H.C. Wainwright Global Investment Conference
    05.09.23 · Business Wire (engl.) · Biocept
    Biocept to Hold Business Update Conference Call on August 30, 2023
    25.08.23 · Business Wire (engl.) · Biocept
    Biocept Reports Second Quarter 2023 Financial Results
    14.08.23 · Business Wire (engl.) · Biocept
    Biocept’s CNSide Cerebrospinal Fluid Assay Featured in Two Oral Presentations at the 2023 SNO/ASCO CNS Cancer Conference
    14.08.23 · Business Wire (engl.) · Biocept
    Biocept Announces the Passing of Board Chair M. Faye Wilson
    14.07.23 · Business Wire (engl.) · Biocept
    Biocept Names Antonino Morales as President and Chief Executive Officer
    20.06.23 · Business Wire (engl.) · Biocept
    Biocept to Present at the Maxim Group Virtual Healthcare Conference Hosted by M-Vest on June 20, 2023
    14.06.23 · Business Wire (engl.) · Biocept
    Scientific Poster Presented at the 2023 ASCO Annual Meeting Highlights Performance of Biocept’s CNSide Versus Cytology
    05.06.23 · Business Wire (engl.) · Biocept
    Biocept Announces Pricing of $5.0 Million Underwritten Public Offering
    25.05.23 · Business Wire (engl.) · Biocept
    Biocept Announces One-for-Thirty Reverse Stock Split
    17.05.23 · Business Wire (engl.) · Biocept